Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy

Read full text
Authors: Huike Ma, XiaWei Zhang, Ruonan Li, Baoquan Qu, Yuchen Liu, Yunran Cui, Tianlu Zhang, Jingxia Zhao
Cited by: 3
References: 141

Abstract

Hypericin, a polycyclic quinone derived from *Hypericum perforatum* (St. John's Wort), has gained attention for its broad pharmacological activities, including anti-inflammatory, antimicrobial, and antitumor effects. It modulates key signaling pathways like NF-κB and MAPK, reducing chronic inflammation and making it effective in treating autoimmune and infectious skin conditions. As a photosensitizer, hypericin also induces apoptosis in abnormal cells through photodynamic therapy (PDT), showing promising results in treating cutaneous T-cell lymphoma (CTCL), psoriasis, and fungal infections. While its solubility and bioavailability remain challenges, hypericin's favorable safety profile and therapeutic potential position it as a valuable option for managing refractory dermatological conditions.

Fields of Study & Subjects

Natural Compound Pharmacology Studies Photodynamic Therapy Research Studies Beetle Biology and Toxicology Studies

Publication details

Journal / source
Drug Design Development and Therapy
Publisher
Informa UK Limited
Volume
Volume 20
Pages
1–21
Publication date
1 January 2026
Language
EN